Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib

SIMPLE SUMMARY: Persistence of infused cells is an important factor that dictates the outcome of adoptive cellular therapy (ACT). DNT therapy is a novel form of ACT with promising result in treating relapsed or refractory AML in preclinical and early clinical studies. However, in vivo kinetics of hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hyeonjeong, Lee, Jong Bok, Khatri, Ismat, Na, Yoosu, D’Souza, Cheryl, Arruda, Andrea, Minden, Mark D., Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533698/
https://www.ncbi.nlm.nih.gov/pubmed/34680188
http://dx.doi.org/10.3390/cancers13205039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533698/
https://www.ncbi.nlm.nih.gov/pubmed/34680188
http://dx.doi.org/10.3390/cancers13205039

Ejemplares similares